Medical Director/BHcare Associate Professor (Adjunct) of Psychiatry, Yale University
Psychiatry
Dr. Dan A. Oren, MD
|
|
Give Review
Doctor Dan A. Oren, MD practices Psychiatry. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. Dr. Dan A. Oren is a published MD. He has 67 publications published. The most current publication "There is nothing new under the sun." He accepts all Medicare patients.
Publications
- Psychiatrist liability and treatment planning in outpatient clinic services: commentary.
- Multicenter, randomized, double-blind, active comparator and placebo-Controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety ...
- A randomized, double-blind, placebo-Controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed demen...
- Management of acute agitation in patients with Bipolar disorder: efficacy and safety of intramuscular aripiprazole.
- Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-Controlled trial.
- Treatment effects of selegiline transdermal system on symptoms of major depressive Disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
- Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.
- Circadian phase shifting, alerting, and antidepressant effects of bright light treatment.
- Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
- Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings.
- Brightening depression.
- Regional brain metabolic correlates of alpha-methylparatyrosine-induced Depressive symptoms: implications for the neural circuitry of depression.
- An open trial of morning light therapy for treatment of antepartum depression.
- Monoamine depletion in unmedicated depressed subjects.
- Effects of light on low nocturnal bilirubin in winter depression: a preliminary report.
- Heisenberg meets photobiology?
- Adaptation to dim light in depressed patients with seasonal affective Disorder.
- Pregnancy outcome following high doses of Vitamin E supplementation.
- Concerning the pathogenesis of idiopathic hypercalciuria.
- Exposure to ultraviolet B radiation during phototherapy.
- Olfactory function in winter seasonal affective Disorder.
- Self-inflicted eye injury.
- Spontaneous eye blink rate in winter seasonal affective Disorder.
- The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.
- Is seasonal affective Disorder a Disorder of circadian rhythms?
- Abnormal circadian rhythms of plasma melatonin and body temperature in the delayed sleep phase syndrome.
- Usage patterns of phototherapy in seasonal affective Disorder.
- 1,25 (OH)2 vitamin D3 levels in seasonal affective Disorder: effects of light.
- Retinal melatonin and dopamine in seasonal affective Disorder.
- Dysphoria after treatment with ondansetron.
- Predictors of response to phototherapy in seasonal affective Disorder.
- Treatment of seasonal affective Disorder with green light and red light.
- Bilirubin, REM sleep, and phototransduction of environMental time cues. A hypothesis.
- A controlled trial of cyanocobalamin (vitamin B12) in the treatment of winter seasonal affective Disorder.
- There is nothing new under the sun.
- The phototherapy light visor: more to it than meets the eye.
- Effects of light on T-cells in HIV-infected subjects are not dependent on history of seasonal affective Disorder.
- Restoration of detectable melatonin after entrainment to a 24-hour schedule in a ''free-running'' man.
- Carbon monoxide poisoning and treatment with hyperbaric oxygen in the subacute phase.
- Genetic polymorphism at the CLOCK gene locus and Major depression.
- Effects of season on electro-oculographic ratio in winter seasonal affective Disorder.
- Serotonin and thermoregulation. Physiologic and pharmacologic aspects of Control revealed by intravenous m-CPP in normal human subjects.
- Preliminary data on the metabolic brain pattern of patients with winter seasonal affective Disorder.
- Effects of phototherapy on electrooculographic ratio in winter seasonal affective Disorder.
- Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective Disorder.
- Exposure to ambient light in patients with winter seasonal affective Disorder.
- Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective Disorder and healthy control subjects. Diurnal responses and nocturnal regulatory ...
- Retinopathy and bright light therapy.
- A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective Disorder: a test of the dopamine hypothesis.
- Bright light therapy for schizoaffective Disorder.
- Light visor treatment for seasonal affective Disorder: a multicenter study.
- Side effects of light therapy in seasonal affective Disorder.
- Transient Depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?
- Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression.
- Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
- Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-Controlled study.
- Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with Schizophrenia: sub-analysis of a double-blind study.
- Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective Disorder: a double-blind, placebo-controlled comparis...
- A multicenter study of the light visor for seasonal affective Disorder: no difference in efficacy found between two different intensities.
- No effect of light on basal glucagon levels in winter seasonal Depressives and comparison subjects.
- Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective Disorder.
- Tweaking the human circadian clock with light.
- Antidepressant effects of ketamine in depressed patients.
- Effect of catecholamine depletion on lithium-induced long-term remission of Bipolar disorder.
- Stimulation of reactive oxygen species production by an antidepressant visible light source.
- The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-Controlled trial.
Schools
Yale University
Conditions Treated
- Alcohol-Induced Mental Disorders
- Bipolar Disorder
- Dysthymia and Cyclothymia (Mood Disorders)
- Impulse Control Disorders
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Yale University School of Medicine
Drug Facts
| NPI NUMBER | 1841435153 | |
| NPPES Provider LastName | OREN | |
| NPPES Provider FirstName | DAN | |
| NPPES Provider ZIPCode | 064011964 | |
| NPPES Provider State | CT | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 4137.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841435153 |
| Last Name Of The Provider | OREN |
| First Name Of The Provider | DAN |
| View All |
Similar Doctors
|
|
Dr. Mihaela Boran, MD |
|
|
Dr. Michael Kligfeld, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Sperling, MD |
|
|
Dr. David W. Wyckoff, MD |
|
|
Dr. Gregory Boyarsky, MD
This Doctor is OpenDoctor Recommended.
|